Capital Research Global Investors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.35B | Buy |
|
|||||
|
2025
Q1 | $1.93B | Buy |
|
|||||
|
2024
Q4 | $1.64B | Buy |
|
|||||
|
2024
Q3 | $1.44B | Buy |
|
|||||
|
2024
Q2 | $791M | Buy |
|
|||||
|
2024
Q1 | $470M | Buy |
|
|||||
|
2023
Q4 | $561M | Buy |
|
|||||
|
2023
Q3 | $493M | Buy |
|
|||||
|
2023
Q2 | $447M | Sell |
|
|||||
|
2023
Q1 | $489M | Buy |
|
|||||
|
2022
Q4 | $198M | Buy |
|